BlackRock Institutional Trust Company, N.A. - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 144 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2016$9,700,000
+0.2%
2,739,976
+14.4%
0.00%
-50.0%
Q3 2016$9,678,000
-7.1%
2,395,596
+1.0%
0.00%0.0%
Q2 2016$10,417,000
+15.9%
2,372,849
-0.2%
0.00%
+100.0%
Q1 2016$8,991,000
-76.2%
2,378,469
-1.2%
0.00%
-83.3%
Q4 2015$37,753,000
+55.5%
2,407,689
+4.5%
0.01%
+50.0%
Q3 2015$24,278,000
-58.4%
2,303,450
-0.6%
0.00%
-55.6%
Q2 2015$58,415,000
-29.9%
2,316,233
-22.5%
0.01%
-30.8%
Q1 2015$83,341,000
+100.6%
2,990,335
+31.4%
0.01%
+85.7%
Q4 2014$41,543,000
+33.1%
2,276,310
-5.5%
0.01%
+40.0%
Q3 2014$31,216,000
-22.7%
2,408,627
-2.6%
0.01%
-28.6%
Q2 2014$40,375,000
-7.1%
2,473,937
+0.6%
0.01%0.0%
Q1 2014$43,453,000
-24.8%
2,459,141
+3.0%
0.01%
-30.0%
Q4 2013$57,800,000
-25.8%
2,387,426
+8.7%
0.01%
-33.3%
Q3 2013$77,848,000
+120.0%
2,197,220
-3.1%
0.02%
+114.3%
Q2 2013$35,385,0002,266,8250.01%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2016
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 844,981$15,421,0007.11%
DOHENY ASSET MANAGEMENT /CA 195,345$3,565,0001.70%
First Light Asset Management, LLC 153,617$2,804,0001.59%
Rhenman & Partners Asset Management AB 175,000$3,194,0000.93%
Iguana Healthcare Management, LLC 100,000$1,825,0000.88%
Eventide Asset Management 288,700$5,269,0000.58%
Bedell Frazier Investment Counselling, LLC 60,820$1,110,0000.54%
STONERIDGE INVESTMENT PARTNERS LLC 214,327$3,911,0000.52%
Fernwood Investment Management, LLC 31,350$572,0000.49%
SUFFOLK CAPITAL MANAGEMENT LLC 168,560$3,076,0000.37%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders